Newsletter | April 8, 2024

04.08.24 -- Exploring Biolistic Particle Delivery Systems


Exploring Biolistic Particle Delivery Systems

The main objective of biolistic particle delivery is to insert genetic material or other molecules into cells or tissues for diverse applications, including genetic engineering, gene therapy, and plant modification. The ability to target substances into specific cells enables researchers to investigate gene functionality, alter genetic traits, or explore novel therapeutic strategies.


Transitioning From Vial To Prefilled Syringe

Understand how formulation development for a prefilled syringe affects manufacturing, driving the industry toward optimizing delivery of injectable products and, ultimately, improving patient care.

Nanoforming: The Patient- And Planet-Centric Approach

By reducing the size of drug particles, nanoforming enables new opportunities – from increasing bioavailability to enabling sustained drug delivery. Learn more about the potential benefits.

Applying Automation To The Manufacture Of Drug Delivery Devices

Automated manufacturing is a powerful but often misunderstood tool available to produce drug delivery and other pharmaceutical devices — whether established designs or innovative new ideas.

Why KinetiSol Is Disrupting Spray Drying

Review a commercially-ready process not only capable of reproducing spray dried dispersions with less manufacturing complexity and environmental impact, but also with the capability to out-design and outperform spray drying.

Taste Masking 101: Optimize Taste And Improve Patient Outcomes

Taste masking is integral for a drug product’s final formulation. It can serve to increase patient acceptability and adherence to a therapy, in turn bolstering regulatory acceptance and commercial potential.


Guiding A Combination Product Down The Path To Regulatory Submission

Real World Dosing Solutions For Patients